Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 12:17 pm Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments Inc. | 600,000 1.900% | -2,008,695 (-77.00%) | View |
| 2024-09-16 10:22 am Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments Inc. | 2,608,695 8.500% | 2,608,695 (New Position) | View |
| 2024-05-24 08:58 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 2,702,935 14.700% | 1,172,935 (+76.66%) | View |
| 2023-02-14 4:35 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | Lynwood Capital Management Inc. | 1,460,000 9.300% | 590,000 (+67.82%) | View |
| 2022-08-01 07:00 am Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | Lynwood Capital Management Inc. | 870,000 5.600% | 85,000 (+10.83%) | View |
| 2022-04-25 4:05 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | Southwest Private Capital Inc. | 782,010 5.100% | 782,010 (New Position) | View |
| 2022-02-14 3:21 pm Unchanged | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments Inc. | 600,000 3.600% | 0 (Unchanged) | View |
| 2022-02-11 8:39 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | Altium Capital Management LP | 900,000 4.700% | 400,000 (+80.00%) | View |
| 2022-02-11 5:47 pm Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | L1 Capital Global Opportunities Master Fund Ltd. | 105,000 11.000% | -895,000 (-89.50%) | View |
| 2022-02-11 5:01 pm Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | Lind Global Macro Fund LP | 36,650 0.200% | -525,950 (-93.49%) | View |
| 2022-02-11 08:00 am Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | Lynwood Capital Management Inc. | 785,000 4.920% | -95,000 (-10.80%) | View |
| 2022-02-04 4:35 pm Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | BIGGER CAPITAL FUND L P | 150,000 11.000% | -2,085,000 (-93.29%) | View |
| 2022-01-20 09:47 am Sale | 13G | BRIACELL THERAPEUTICS CORP BCTX | Empery Asset Management LP | 500,000 2.520% | -11,403 (-2.23%) | View |
| 2022-01-03 7:24 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | SABBY MANAGEMENT LLC | 756,883 11.000% | 201,883 (+36.38%) | View |
| 2021-09-20 5:25 pm Sale | 13D | BRIACELL THERAPEUTICS CORP BCTX | Hyperscale Data Inc. GPUS | 715,000 4.670% | -170,000 (-19.21%) | View |
| 2021-09-13 08:30 am Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | K.J. Harrison & Partners Inc | 959,870 6.230% | 959,870 (New Position) | View |
| 2021-09-07 4:05 pm Unchanged | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 1,530,000 10.000% | 0 (Unchanged) | View |
| 2021-08-17 4:04 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | Lynwood Capital Management Inc. | 880,000 5.800% | 880,000 (New Position) | View |
| 2021-08-09 06:01 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | Hyperscale Data Inc. GPUS | 885,000 6.150% | 885,000 (New Position) | View |
| 2021-08-04 09:43 am Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 1,530,000 10.000% | 805,000 (+111.03%) | View |